Novartis publishes Q2 impact and sustainability update to investors

(AWP Alliance News) - Novartis outlined progress on its impact and sustainability agenda, keeping a net-zero target of 2040 while stepping up work on value-chain emissions, which it flagged as dominated by Scope 3. The group reported a 17% cut in Scope 3 emissions by 2025 versus a 2022 baseline, leaving 25% to meet its 2030 goal, with supplier engagement positioned as the main lever given purchased goods and services account for about 80% of Scope 3. It also highlighted life-cycle assessments showing drug-substance manufacturing as the largest emissions source, guiding actions on process efficiency, renewable energy, packaging, and logistics shifts such as moving freight from air to sea where feasible. On water stewardship, it reiterated a 2030 commitment to eliminate water-quality impacts from manufacturing effluents across its sites and API suppliers, reporting 97% of manufacturing sites and 100% of suppliers in scope met its standard in 2025. Novartis also updated on AI governance, citing a risk-based compliance framework aligned with emerging regulation and announcing an AI-focused investor session set for Nov. 19, 2026.

https://docs.publicnow.com/6EEFC18D242165C2E021E48BB8EB779838F2BE2F

Disclaimer: This news brief was created using generative artificial intelligence. Novartis AG published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.